BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24727996)

  • 1. The evolution of clinical trials for infant acute lymphoblastic leukemia.
    Kotecha RS; Gottardo NG; Kees UR; Cole CH
    Blood Cancer J; 2014 Apr; 4(4):e200. PubMed ID: 24727996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.
    Tomizawa D; Koh K; Hirayama M; Miyamura T; Hatanaka M; Saikawa Y; Ishii E
    Pediatr Blood Cancer; 2009 Jul; 52(7):808-13. PubMed ID: 19229974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies.
    Mustafa O; Abdalla K; AlAzmi AA; Elimam N; Abrar MB; Jastaniah W
    J Oncol Pharm Pract; 2019 Dec; 25(8):1831-1838. PubMed ID: 30518307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and treatment of pediatric acute lymphoblastic leukemia.
    Lee JW; Cho B
    Korean J Pediatr; 2017 May; 60(5):129-137. PubMed ID: 28592975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute lymphoblastic leukemia in children: current status, controversies, and future perspective.
    Miller LP; Miller DR
    Crit Rev Oncol Hematol; 1983; 1(2):129-97. PubMed ID: 6397264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
    Kimby E; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.
    Tallen G; Ratei R; Mann G; Kaspers G; Niggli F; Karachunsky A; Ebell W; Escherich G; Schrappe M; Klingebiel T; Fengler R; Henze G; von Stackelberg A
    J Clin Oncol; 2010 May; 28(14):2339-47. PubMed ID: 20385996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
    Schmiegelow K; Forestier E; Hellebostad M; Heyman M; Kristinsson J; Söderhäll S; Taskinen M;
    Leukemia; 2010 Feb; 24(2):345-54. PubMed ID: 20010622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.
    Oriol A; Vives S; Hernández-Rivas JM; Tormo M; Heras I; Rivas C; Bethencourt C; Moscardó F; Bueno J; Grande C; del Potro E; Guardia R; Brunet S; Bergua J; Bernal T; Moreno MJ; Calvo C; Bastida P; Feliu E; Ribera JM;
    Haematologica; 2010 Apr; 95(4):589-96. PubMed ID: 20145276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infant acute leukemia].
    Brethon B; Cavé H; Fahd M; Baruchel A
    Bull Cancer; 2016 Mar; 103(3):299-311. PubMed ID: 26826739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.
    Dördelmann M; Reiter A; Borkhardt A; Ludwig WD; Götz N; Viehmann S; Gadner H; Riehm H; Schrappe M
    Blood; 1999 Aug; 94(4):1209-17. PubMed ID: 10438708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult acute leukemia.
    Cripe LD
    Curr Probl Cancer; 1997; 21(1):1-64. PubMed ID: 9058027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.
    Reaman GH; Sposto R; Sensel MG; Lange BJ; Feusner JH; Heerema NA; Leonard M; Holmes EJ; Sather HN; Pendergrass TW; Johnstone HS; O'Brien RT; Steinherz PG; Zeltzer PM; Gaynon PS; Trigg ME; Uckun FM
    J Clin Oncol; 1999 Feb; 17(2):445-55. PubMed ID: 10080584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
    Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G
    J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.
    Ko RH; Ji L; Barnette P; Bostrom B; Hutchinson R; Raetz E; Seibel NL; Twist CJ; Eckroth E; Sposto R; Gaynon PS; Loh ML
    J Clin Oncol; 2010 Feb; 28(4):648-54. PubMed ID: 19841326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.